Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATEZOLIZUMAB Cause Multiple organ dysfunction syndrome? 136 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Multiple organ dysfunction syndrome have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.4% of all adverse event reports for ATEZOLIZUMAB.

136
Reports of Multiple organ dysfunction syndrome with ATEZOLIZUMAB
0.4%
of all ATEZOLIZUMAB reports
117
Deaths
69
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From ATEZOLIZUMAB?

Of the 136 reports, 117 (86.0%) resulted in death, 69 (50.7%) required hospitalization, and 23 (16.9%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

Yes, Multiple organ dysfunction syndrome is listed as a known adverse reaction in the official FDA drug label for ATEZOLIZUMAB.

What Other Side Effects Does ATEZOLIZUMAB Cause?

Death (3,591) Off label use (2,340) Disease progression (1,828) Pyrexia (1,599) Diarrhoea (1,490) Fatigue (1,253) Anaemia (1,195) Pneumonia (1,036) Nausea (953) Dyspnoea (938)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which ATEZOLIZUMAB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

ATEZOLIZUMAB vs ATLANTIC SALMON OIL ATEZOLIZUMAB vs ATOGEPANT ATEZOLIZUMAB vs ATOMOXETINE ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE ATEZOLIZUMAB vs ATORVASTATIN

Related Pages

ATEZOLIZUMAB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome ATEZOLIZUMAB Demographics